SHH · Key Statistics

Gan & Lee Pharmaceuticals. (603087.SS) Key Statistics

$72.00 SHH: 603087.SS

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Gan & Lee Pharmaceuticals. (603087.SS), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	0.00
P/B ratioShare price divided by book value per share.	0.00
P/S ratioMarket value divided by annual revenue.	0.00

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	0.00%
Operating marginRevenue left after operating costs.	0.00%
Net marginRevenue left after every cost, including tax and interest.	0.00%
Return on equityProfit as a percentage of shareholders’ equity.	0.00%
Return on assetsProfit as a percentage of total assets.	0.00%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	0.00
Quick ratioThe same, excluding inventory.	0.00
Debt to equityTotal borrowings against shareholders’ equity.	0.00

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$0.00
Book value per shareShareholders’ equity divided by shares outstanding.	$0.00
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$0
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$0
EmployeesReported headcount.	5,309

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Gan & Lee Pharmaceuticals. (603087.SS) statistics — frequently asked questions

How much debt does Gan & Lee Pharmaceuticals. carry?

Gan & Lee Pharmaceuticals. (603087.SS) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.